DESCRIPTION Prior to his 2025 prostate cancer diagnosis, Stuart Hopgood experienced no symptoms. But a visit to his general practitioner included blood work, which revealed a PSA of 74.2! Stuart was referred to a urologist, who called for a needle-point biopsy. The biopsy not only showed Stuart that he had Stage IV prostate cancer, but that it had metastasized to his pelvic area, a rib and his clavicle. He put on Trelstar, a form of hormonal therapy, six weeks of radiatio